|
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e
12/1/2008: New Advances in the Chemotherapy of Tuberculosis—Part 3 of 3: New Mechanisms Associated with Resistance to Antituberculosis Drugs
Tawanda Gumbo
Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas
Topics Discussed: adenosine triphosphate; antitubercular agents; chemotherapy regimen; dna gyrase; drug resistance; drug resistance, multiple; extrapulmonary tuberculosis; fluoroquinolones; isoniazid; multidrug efflux pump activity; multidrug-resistant tuberculosis; mycobacterium tuberculosis; mycolic acids; pharmacodynamics; pharmacokinetics; pharmacotherapy; pyrazinamide; rifampin; streptomycin; tuberculosis.
Related to Chapter 47. Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy; View in chapter;
Excerpt:
"
View in chapter
..."
The content above is only an excerpt.
For full access, log into an existing user account below, purchase an annual subscription, or purchase a short-term subscription to the complete website.
|
|
|
|
|